The quest to find chiral catalysts capable of achieving high enantiomeric excess for a variety of asymmetric transformations has been an ongoing endeavor for the past 40 years. One of the most relevant reactions used to evaluate the different chiral ligands and complexes is the asymmetric hydrogenation. This technology has been one of the most studied and utilized in industry and has been rewarded the Nobel Prize in 2001 for the outstanding work accomplished by Professor Ryoji Noyori and William S. Knowles.
Figure 1.Structure Image
The research team at Takasago International Corporation developed a series of ligands and complexes for a plethora of catalyzed asymmetric reactions. Based on a biphenyl architecture, several phosphine ligands have been synthesized. Two large families of ligands can be distinguished, BINAP and SEGPHOS®. BINAP is based on a bis naphthalene backbone with different phosphine derivatives. SEGPHOS® is based on a bis(1,3-benzodioxole) with different phosphine substituents. BINAP and SEGPHOS® are highly reactive and selective in a variety of asymmetric hydrogenation. In conjunction with ruthenium, rhodium, palladium and copper complexes, these ligands allow for enantioselectivities of up to >99%.
Chen et al. presented the asymmetric synthesis of arylated coumarins. The importance of this transformation with coumarin precursors is illustrated with the synthesis of (R)-tolterodine, a urological drug that can be readily obtain follwing the asymmetric arylation. Using SEGPHOS® and Rh(acac)(C2H4)2, the researchers were able to obtain the desired arylated coumarins with a yield of 88% and ee of 99.6%.
Figure 2.Rhodium-Catalyzed 1,4-Addition of Arylboronic Acids to Coumarins Image
Tomita et al. developed a new catalytic enantioselective method for chiral alcohol and diarylmethanol synthesis. This new method is a great alternative to the kinetic resolution using the Sharpless epoxidation or the asymmetric addition of alkenylzinc reagents to carbonyl compounds, for the synthesis of chiral allylic alcohols. Furthermore, the transformation can be achieved using air and moisture stable alkenylsilanes. Using CuF2·H2O with DTBM-SEGPHOS®, the aryl-aldehyde is reacted with a variety of trimethoxy silane derivatives. Excellent enantioselectivities were obtained from a wide range of aldehydes.
Figure 3.Copper Catalyzed Asymmetric Alkenylation and Phenylation Image
Lipshutz et al. developed a new method for asymmetric hydrosilylations of various ketones using a preformed DTBM-SEGPHOS®CuH species in the presence of excess polymethylhydrosiloxane. High yields and ees were reported for a variety of ketones. These chiral building blocks are precursors for the synthesis of various drugs and naturally occurring molecules.
Figure 4.Asymmetric Hydrosilylation
Ohkuma et al. reported a practical asymmetric hydrogenation reactions using mild hydrogen pressure with a wide scope. The access to chiral alcohol from amino ketone is important for the synthesis of physiologically active compounds. In this new process, a diphosphine/diamine Ru catalyst is utilized. This complex is based on DM-BINAP and 1,1-di-4-anysil-2-isopropyl-1,2-ethylenediamine (DAIPEN) and a ruthenium complex. Using a loading as low as 0.01 mol% of catalyst, the hydrogenation of various amino ketones was conducted with up to 99% yield and up to 99.8% ee. To illustrate the relevance of this new catalyst, Okuma et al. synthesized a series of known molecules used in drugs.
Figure 5.Asymmetric Hydrogenation of Amino Ketones Image
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.